SEC Form 4 · accession 0001001250-16-000213
ESTEE LAUDER COMPANIES INC · EL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald S Lauder
Officer — Chairman, Clinique Labs LLC · 10% Owner
Period of report
Aug 31, 2016
Accepted (ET)
Sep 1, 2016 · 5:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001250
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF2 | Aug 31, 2016 | C | 608,500 | — | A | 608,500 | D | |
| Class A Common StockF3,F4 | Aug 31, 2016 | S | 174,184 | $89.10 | D | 434,316 | D | |
| Class A Common StockF3,F5 | Sep 1, 2016 | S | 324,799 | $88.80 | D | 109,517 | D | |
| Class A Common StockF3,F6 | Sep 1, 2016 | S | 1,017 | $89.40 | D | 108,500 | D | |
| Class A Common StockF7 | Sep 1, 2016 | G | 19,600 | — | D | 88,900 | D | |
| Class A Common StockF7 | Sep 1, 2016 | G | 6,450 | — | D | 82,450 | D | |
| Class A Common StockF7 | Sep 1, 2016 | G | 21,700 | — | D | 60,750 | D | |
| Class A Common StockF7 | Sep 1, 2016 | G | 20,000 | — | D | 40,750 | D | |
| Class A Common StockF7 | Sep 1, 2016 | G | 27,250 | — | D | 13,500 | D | |
| Class A Common StockF7 | Sep 1, 2016 | G | 13,500 | — | D | 0 | D | |
| Class A Common StockF8 | holding | — | — | — | 6,364 | I | by Descendants of RSL 1966 Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Class B Common StockF7,F2 | — | Aug 31, 2016 | C | 608,500 | D | — | — | Class A Common Stock | 608,500 | 9,403,531 | D |
| Class B Common StockF8,F2 | — | holding | — | — | — | — | — | Class A Common Stock | 6,364 | 6,364 | I |
Explanation of responses
- F1Ronald S. Lauder ("RSL") converted shares of Class B Common Stock into an equal number of shares of Class A Common Stock.
- F2There is no exercise or conversion price for the Class B Common Stock. Shares of Class B Common Stock (i) may be converted immediately on a one-for-one basis by the holder into shares of Class A Common Stock and (ii) are automatically converted into Class A Common Stock on a one-for-one basis upon transfer to a person or entity that is not a "Permitted Transferee" (as defined in Issuer's Restated Certificate of Incorporation) or soon after a record date for a meeting of stockholders where the outstanding Class B Common Stock constitutes less than 10% of the outstanding shares of Common Stock of the Issuer.
- F3The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- F4Sales prices range from $88.79 to $89.27 per share, inclusive.
- F5Sales prices range from $88.37 to $89.36 per share, inclusive.
- F6Sales prices range from $89.37 to $89.44 per share, inclusive.
- F7Not applicable.
- F8RSL disclaims beneficial ownership of these shares to the extent he does not have a pecuniary interest in such securities.